Age and amyloid effects on human central nervous system amyloid-beta kinetics. - Wikidata - awgldk - TriplyDB

Age and amyloid effects on human central nervous system amyloid-beta kinetics.

Age and amyloid effects on human central nervous system amyloid-beta kinetics.

http://www.wikidata.org/entity/Q35987665

about

Expanding the Repertoire of Biomarkers for Alzheimer's Disease: Targeted and Non-targeted Approaches Pathophysiologic relationship between Alzheimer's disease, cerebrovascular disease, and cardiovascular risk: A review and synthesis Efficacy and Safety of Plasma Exchange with 5% Albumin to Modify Cerebrospinal Fluid and Plasma Amyloid-β Concentrations and Cognition Outcomes in Alzheimer's Disease Patients: A Multicenter, Randomized, Controlled Clinical Trial.Whole exome sequence-based association analyses of plasma amyloid-β in African and European Americans; the Atherosclerosis Risk in Communities-Neurocognitive Study.Propagation of Aß pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies.Associations Between β-Amyloid Kinetics and the β-Amyloid Diurnal Pattern in the Central Nervous System.Overcoming translational barriers impeding development of Alzheimer's disease modifying therapies.Biochemically-defined pools of amyloid-β in sporadic Alzheimer's disease: correlation with amyloid PET.Diversity of Amyloid-beta Proteoforms in the Alzheimer's Disease Brain.Impaired synaptic function is linked to cognition in Parkinson's disease.The effects of noncoding aquaporin-4 single-nucleotide polymorphisms on cognition and functional progression of Alzheimer's disease.A randomized controlled study to evaluate the effect of bexarotene on amyloid-β and apolipoprotein E metabolism in healthy subjects A randomized, exploratory molecular imaging study targeting amyloid β with a novel 8-OH quinoline in Alzheimer's disease: The PBT2-204 IMAGINE study.Preventing Neurodegenerative Memory Loss in Hopfield Neuronal Networks Using Cerebral Organoids or External Microelectronics.The Emerging Relationship Between Interstitial Fluid-Cerebrospinal Fluid Exchange, Amyloid-β, and Sleep.Effect of sleep on overnight CSF amyloid-β kinetics.Amyloid β concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosis.Small-molecule PET Tracers for Imaging Proteinopathies.Mathematical Modeling of Protein Misfolding Mechanisms in Neurological Diseases: A Historical Overview.Study of the Influence of Age in 18F-FDG PET Images Using a Data-Driven Approach and Its Evaluation in Alzheimer's Disease.NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.Amyloid-β Plaques in Clinical Alzheimer's Disease Brain Incorporate Stable Isotope Tracer In Vivo and Exhibit Nanoscale Heterogeneity.Targeting Beta-Amyloid at the CSF: A New Therapeutic Strategy in Alzheimer's Disease.Relevance of Aβ42/40 Ratio for Detection of Alzheimer Disease Pathology in Clinical Routine: The PLMR Scale.Tau Kinetics in Neurons and the Human Central Nervous System Aging and are determinative factors of plasma A42 levels A systematic meta-analysis of oxygen-to-glucose and oxygen-to-carbohydrate ratios in the resting human brain Transcriptional network analysis of human astrocytic endfoot genes reveals region-specific associations with dementia status and tau pathology The BACE-1 inhibitor CNP520 for prevention trials in Alzheimer's disease

P2860

Q26770708-C7353F9A-8D58-44E5-B0E5-BFD88D479EDB Q30235369-027E4625-53F4-44EE-BCE7-18FB217A339D Q37589619-A682425C-6EBF-4AAA-A585-47BD05F99DFA Q38680904-5E2AE62F-1282-4B9B-ACB8-298FB8B145B2 Q38682621-81BA03B5-C1DA-4885-B220-1C4FC15086D1 Q38780800-3A4645C6-4827-4F62-8D69-975F24C45A06 Q38802634-64BE85ED-FAAF-46BC-9296-173A285D5EBA Q38850382-658584F7-91D5-41F3-9148-3865FE0BA213 Q41529132-57C2C829-F06F-4CB0-8060-CB1731B7DE96 Q42373778-74C8F13B-3F2C-4392-8CE2-DD399AEE48BC Q42654261-39E37C7D-B091-44C2-BB7D-8903FC886BB9 Q42689665-37B5992E-F08E-4D7A-A131-DFDC17F612CE Q47145223-A1063DB8-0265-42EE-A2C4-4EBE563A72B8 Q47192077-94654E18-42DB-43CE-AC95-2C46B4C102B8 Q47246772-D5C53DF0-E15A-4A4A-A219-74ED356BC348 Q47563259-E8B91DCA-8B7B-4331-9E78-BD0066236E19 Q47572013-7741D039-404C-4916-85B9-7339300E7BE6 Q47926474-2C4C4ADE-3C45-4DBF-B598-651387AA2A03 Q49884955-8FBB6097-22FF-47BD-80E9-DF4D4FCD3C84 Q51759215-C6C6C9F1-03A0-4F36-8DAE-E42DC7238DF8 Q52589491-329965EC-6287-4999-9538-CB02E94341A2 Q52603640-56F2A61E-4BD1-43F8-9679-CBAD082B33AC Q53513690-675149DB-FF22-4AB0-8F61-F403802C15A8 Q54960062-2F4DAEA1-F51D-41BC-AF53-5A46FFE4D794 Q57215461-839F9A69-262C-4720-B391-D2EBF2F74A16 Q57822409-2E9BA4E2-443A-42C3-8336-690B772A7F45 Q58701410-8F4EBD8C-E119-4EC2-B9FD-D71E57762488 Q58770954-AF7483C2-542B-41E9-918F-C277BCCCA42F Q59133137-FACC1236-4135-478F-88C7-B1D14E18FCEB

P2860

Age and amyloid effects on human central nervous system amyloid-beta kinetics.

http://www.wikidata.org/entity/Q35987665

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Age and amyloid effects on human central nervous system amyloid-beta kinetics.

@ast

Age and amyloid effects on human central nervous system amyloid-beta kinetics.

@en

type

label

Age and amyloid effects on human central nervous system amyloid-beta kinetics.

@ast

Age and amyloid effects on human central nervous system amyloid-beta kinetics.

@en

prefLabel

Age and amyloid effects on human central nervous system amyloid-beta kinetics.

@ast

Age and amyloid effects on human central nervous system amyloid-beta kinetics.

@en

P1433

Q35987665-06D67BD3-E5E5-4AD3-ADBF-E886FF358AFD

P1476

Q35987665-0E61E54F-5253-4C95-9D9E-2AB2CE132FB9

P2093

Q35987665-0C0985CC-326D-4DDF-8767-C2038230A8C1

Q35987665-19E81BB6-CF76-43D7-B6D8-D121DE22FA8F

Q35987665-43FC9628-6491-484B-BDC4-12D7350F111E

Q35987665-4527F11F-CE6B-456F-9D21-4CF727D4EA3B

Q35987665-5374679D-392C-44EB-813D-CA9011C1F4C3

Q35987665-6A862DDE-856A-4A67-8495-7CFF68A2C691

Q35987665-7C332805-64F4-42CD-9F29-930F782126DF

Q35987665-8C219487-266D-4527-AF0B-39D47B2F9C53

Q35987665-959FCB9C-66F6-4FF4-AA33-6AF98DF03190

Q35987665-99BB4AA8-39B0-4FEC-9DB2-3DD1AD9656F1

P2860

Q35987665-056AFE86-FA59-4647-82E6-83D63FF8ACB7

Q35987665-0C07A9B8-55A0-43DB-9703-719B5F295BCF

Q35987665-122930B0-B2B4-4148-8574-8B1ECC70F911

Q35987665-1E8E6DDA-58C3-40D0-A136-88B85F3942CE

Q35987665-1EA8A6A7-2F13-4FB7-9346-B99CB6D8B5C6

Q35987665-2001DE8F-E2A2-4963-92F7-1F264DC70E55

Q35987665-2AD2D13E-7082-45E4-AA72-F852D2235272

Q35987665-2ED70618-6B4C-4F0F-A9E6-514EABA82E01

Q35987665-34A88996-B87B-43E5-A4DB-545F4A7B42A3

Q35987665-3744FB76-B341-4653-8B43-4D39D4D2D9AD

P304

Q35987665-D16D34A5-4D37-45E1-BA4E-B8DF1BA05AD1

P31

Q35987665-B8260BB1-C0EF-473E-830F-2FAC69C64B25

P356

Q35987665-C814FF73-4051-473C-AFFA-05AC1D74857D

P433

Q35987665-6F98D693-58B0-4962-8084-4A50A679032D

P478

Q35987665-11A03313-2E38-4A6F-B014-92FB7ED7111D

P50

Q35987665-2913BBCA-14F6-46CE-BC47-EC7AD5AA65D3

Q35987665-B05CF8B5-2289-42F1-97D0-D99F932EE647

Q35987665-BCC30EA5-24E7-4230-9026-37F40D0F58F8

Q35987665-BD839E68-B531-4FBD-A0E7-8D24BC838564

Q35987665-C849D958-1035-4061-8CDC-B82111856A0D

P577

Q35987665-59A872BA-BA3A-419D-A982-DEEB1C6E7FC0

P5875

Q35987665-325FDB61-8864-4E86-92FC-462EC27FD8FE

P698

Q35987665-34414B57-FF26-47A0-817D-5D554C1A9488

P932

Q35987665-6E563CD8-88DA-4326-991D-8C7BA8E218F6

P356

P1433

Annals of Neurology

P1476

Age and amyloid effects on human central nervous system amyloid-beta kinetics.

@en

P2093

Bruce W Patterson

http://www.w3.org/2001/XMLSchema#string

Chengjie Xiong

http://www.w3.org/2001/XMLSchema#string

Donald L Elbert

http://www.w3.org/2001/XMLSchema#string

Kevin Yarasheski

http://www.w3.org/2001/XMLSchema#string

Kwasi G Mawuenyega

http://www.w3.org/2001/XMLSchema#string

Lily Zhang

http://www.w3.org/2001/XMLSchema#string

Robert Chott

http://www.w3.org/2001/XMLSchema#string

Shengmei Ma

http://www.w3.org/2001/XMLSchema#string

Tom Kasten

http://www.w3.org/2001/XMLSchema#string

Vitaliy Ovod

http://www.w3.org/2001/XMLSchema#string

P2860

A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline

Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease

Human amyloid-beta synthesis and clearance rates as measured in cerebrospinal fluid in vivo

Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease

Candidate gene for the chromosome 1 familial Alzheimer's disease locus

Amyloid-beta isoform metabolism quantitation by stable isotope-labeled kinetics

The Clinical Dementia Rating (CDR): current version and scoring rules

Decreased clearance of CNS beta-amyloid in Alzheimer's disease

Clinical and biomarker changes in dominantly inherited Alzheimer's disease.

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers

P304

439-453

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ANA.24454

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

78

http://www.w3.org/2001/XMLSchema#string

P50

Randall J. Bateman

Tammie L. Benzinger

David M. Holtzman

P577

2015-06-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

277725270

http://www.w3.org/2001/XMLSchema#string

P698

26040676

http://www.w3.org/2001/XMLSchema#string

P932

4546566

http://www.w3.org/2001/XMLSchema#string